Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REBAMIPIDE vs REGADENOSON: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REBAMIPIDE vs REGADENOSON: Safety Overview

Metric REBAMIPIDE REGADENOSON
Total FAERS Reports 427 3,071
Deaths Reported 32 84
Death Rate 7.5% 2.7%
Hospitalizations 222 321
Average Patient Age 63.7 yrs 68.1 yrs
% Female Patients 56.6% 58.6%
FDA Approval Date N/A Apr 10, 2008
Manufacturer N/A Apotex Corp.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription